Funding for this research was provided by:
National Cancer Institute (R03CA172738, 2RO1CA129933)
National Institute of Biomedical Imaging and Bioengineering (2U01EB012493)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007191)
Howard Hughes Medical Institute
Burroughs Wellcome Fund
American Association for Cancer Research
National Foundation for Cancer Research
Received: 27 January 2018
Accepted: 9 July 2018
First Online: 18 July 2018
Ethics approval and consent to participate
: All clinical studies were approved by the Dana-Farber Harvard Cancer Center (DF/HCC) Institutional Review Board (Protocol 05–300). Patients were all prospectively consented on protocol 05–300 for this project.
: Not Applicable.
: There are no conflicts to report for all authors.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.